G Pasterkamp
Overview
Explore the profile of G Pasterkamp including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
123
Citations
1678
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Brand Kanters A, Roozendaal N, Parr N, Pasterkamp G, Urbanus R, Korporaal S, et al.
PLoS One
. 2024 Jun;
19(6):e0304800.
PMID: 38924073
Background: Despite Antiplatelet therapy (APT), cardiovascular patients undergoing revascularisation remain at high risk for thrombotic events. Individual response to APT varies substantially, resulting in insufficient protection from thrombotic events due...
2.
Wesseling M, Diez-Benavente E, Mokry M, den Ruijter H, Pasterkamp G
Vascul Pharmacol
. 2024 Feb;
154:107286.
PMID: 38408531
The rapid advancements in genome-scale (omics) techniques has created significant opportunities to investigate complex disease mechanisms in tissues and cells. Nevertheless, interpreting -omics data can be challenging, and pathway enrichment...
3.
Reijrink M, van Ark J, Lexis C, Visser L, Lodewijk M, van der Horst I, et al.
Cardiovasc Diabetol
. 2022 May;
21(1):72.
PMID: 35549955
Background: Individuals with type 2 diabetes mellitus (T2DM) have an increased risk for developing macrovascular disease (MVD) manifested by atherosclerosis. Phenotypically and functionally different monocyte subsets (classical; CD14CD16, non-classical; CD14CD16,...
4.
Demandt J, Dubois L, van Kuijk K, Zatovicova M, Jin H, Parkkila S, et al.
Sci Rep
. 2021 Jan;
11(1):425.
PMID: 33432108
Hypoxia is prevalent in atherosclerotic plaques, promoting plaque aggravation and subsequent cardiovascular disease (CVD). Transmembrane protein carbonic anhydrase IX (CAIX) is hypoxia-induced and can be shed into the circulation as...
5.
Nederhoff M, Fransen D, Verlinde S, Brans M, Pasterkamp G, Bleys R
Auton Neurosci
. 2019 Sep;
221:102580.
PMID: 31491700
Objectives: In cardiac ischemia, acute inflammatory responses further increase the detrimental effect on myocardial tissue. Since vagus nerve stimulation (VS) attenuates inflammatory responsiveness this study examines the effect of VS...
6.
Zwetsloot P, Kouwenberg L, Sena E, Eding J, den Ruijter H, Sluijter J, et al.
Sci Rep
. 2018 Apr;
8(1):6047.
PMID: 29643426
A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has been fixed in the paper.
7.
Wesseling M, Sakkers T, de Jager S, Pasterkamp G, Goumans M
Vascul Pharmacol
. 2018 Feb;
106:1-8.
PMID: 29471141
Cell transdifferentiation occurs during cardiovascular development or remodeling either as a pathologic feature in the progression of disease or as a response to injury. Endothelial-to-Mesenchymal Transition (EndMT) is a process...
8.
van Asten I, Schutgens R, Baaij M, Zandstra J, Roest M, Pasterkamp G, et al.
J Thromb Haemost
. 2018 Jan;
16(4):689-698.
PMID: 29337406
Summary: Background Light transmission aggregometry (LTA) is the most commonly used test for the diagnosis of platelet function disorders (PFDs), but has moderate sensitivity for mild PFDs. Flow cytometry has...
9.
Brand A, Korporaal S, Urbanus R, Pasterkamp G, de Borst G
Ned Tijdschr Geneeskd
. 2017 Dec;
161:D1700.
PMID: 29219795
- Platelet aggregation inhibitors, also known as antiplatelet therapy (APT), are prescribed for the prevention of secondary cardiovascular events (CVE) after endovascular revascularization procedures.- Platelet aggregation inhibitors are not equally...
10.
Keustermans G, Kofink D, Eikendal A, de Jager W, Meerding J, Nuboer R, et al.
Sci Rep
. 2017 Dec;
7(1):16826.
PMID: 29203885
Childhood obesity coincides with increased numbers of circulating classical CD14CD16 and intermediate CD14CD16 monocytes. Monocytes are key players in the development and exacerbation of atherosclerosis, which prompts the question as...